Tiziana Life Sciences Ltd.: Tiziana Life Sciences PLC (TLSA: NASDAQ) Releases Research Report: Clinical Improvements for 2nd SPMS Patient
Zacks Small-Cap Research Note By John D. Vandermosten, CFA NEW YORK, June 09, 2022positive clinical results for its second secondary progressive multiple sclerosis. Based on the data gathered
Hana Malik Intranasalforalumab Firstspmspatient Johnd Vandermosten Cap Research Tiziana Life Sciences Ltd Access Program
Source: finanznachrichten.de